Menu Search

HBM Healthcare Investments announces investment of USD 30 million in Harmony Biosciences

Harmony Biosciences, a privately held US-biopharmaceutical company, announced yesterday that it raised USD 270 million from a syndicate of investors. HBM Healthcare Investments participated with USD 30 million in this financing. Dr Andreas Wicki, Chief Executive Officer of HBM Healthcare Investments, will join the Board of Harmony.